Adc Therapeutics Sa (ADCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 10-2001 | 10-2000 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 348,600 | 217,300 |
| Marketable Securities | 73,200 | 1,136,900 |
| Receivables | 459,100 | 702,700 |
| Inventories | 253,600 | 486,100 |
| Income taxes - deferred | 107,000 | N/A |
| TOTAL | $1,305,200 | $2,650,900 |
| Non-Current Assets | ||
| PPE Net | 614,000 | 608,600 |
| Intangibles | 140,100 | 0 |
| Other Non-Current Assets | 440,400 | 711,000 |
| TOTAL | $1,194,500 | $1,319,600 |
| Total Assets | $2,499,700 | $3,970,500 |
| Liabilities | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | 162,000 | 231,600 |
| Accrued Expenses | 229,900 | 241,200 |
| TOTAL | $599,400 | $1,041,300 |
| Non-Current Liabilities | ||
| Long Term Debt | 3,000 | 16,500 |
| Other Non-Current Liabilities | 3,900 | 0 |
| TOTAL | $6,900 | $16,500 |
| Total Liabilities | $606,300 | $1,057,800 |
| Shareholders' Equity | ||
| Shares Outstanding, K | 113,438 | N/A |
| Common Shares | 158,400 | 154,100 |
| Retained earnings | 471,700 | 1,759,400 |
| Other shareholders' equity | 7,200 | 45,200 |
| TOTAL | $1,893,400 | $2,912,700 |
| Total Liabilities And Equity | $2,499,700 | $3,970,500 |